Oncology

Top Story

Occult HBV does not affect HCC resection outcomes

July 24, 2017

The presence of hepatitis B core antibody, or HBcAb, did not affect the outcomes of hepatic resection in patients with either hepatitis C-related or non-B, non-C hepatocellular carcinoma, according to results of a recent study. However, the data showed a possible link between occult hepatitis B infection and hepatocarcinogenesis in patients with non-B, non-C HCC.

“Because measurement of HBcAb is not included in the regular screening protocol for HBV infection at many institutions, the actual prognostic influence of HBcAb-positivity in HCC patients remains unclear,” Shinji Itoh, MD, PhD, from the Graduate School of Medical Sciences, Fukuoka, Japan, and colleagues wrote. “Given the apparently high proportion of patients with a history of HBV, the clinical features of the HBcAb-positive subgroup of [non-B, non-C] HCC or HCV-related HCC patients need to be explored to allow for better clinical management of HCC.”

In the Journals

HCC risk increases in men with HBV, multiple metabolic risk factors

July 17, 2017
Men aged 40 to 65 years with chronic hepatitis B and a high burden of metabolic risk factors had increased risk for hepatocellular carcinoma, especially is they were…
Feature

Targeting MSM with HIV: Treatment as Prevention in the Netherlands

HCV Next, July/August
The Dutch government has been taking comprehensive steps to deal with HCV. In November 2015, they ruled to treat all patients with HCV, regardless of age, cirrhosis or…
In the Journals

Low lymphocyte infiltration in HCC linked to recurrence, poor OS

July 14, 2017
Recently published data revealed a significant association between low lymphocyte infiltration in hepatocellular carcinoma tumors and higher recurrence rates and poor…
More Headlines »
CME

Rapid Response from Barcelona: New Data in HCV Treatment

This activity is supported by an educational grant from AbbVie and Merck & Co., Inc.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »
GI Bookshelf

Chapter 26: Medical Management of Severe Ulcerative Colitis

From Ulcerative Colitis: The Complete Guide to Medical Management
More »
Resource Centers
International Liver Congress

International Liver Congress

Video
Meeting News Coverage

VIDEO: ILC presentations focus on advances in hepatocellular carcinoma

April 12, 2014
More »
Advertisement
Advertisement